All In Biotech

Drug Trial Radar · NCT02161757

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist.

Last checked: Nov 20, 2026Latest source record: Aug 28, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,207 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,207

Actual

Start

Jun 13, 2014

Primary completion

Feb 28, 2017

Study completion Jul 18, 2017

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 12, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist

Conditions

  • Uncontrolled Asthma

Interventions

  • TralokinumabBiological

    Subcutaneous injection

  • PlaceboOther

    Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualised Asthma Exacerbation Rate (AAER) up to Week 52Time frame: Baseline (Week 0) up to Week 52

Locations

243 sites in 15 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama

  • Research Site

    Phoenix, Arizona

  • Research Site

    Arcadia, California

  • Research Site

    Los Angeles, California

  • Research Site

    Los Angeles, California

  • Research Site

    Newport Beach, California

  • Research Site

    Poway, California

  • Research Site

    San Jose, California

  • Research Site

    Tustin, California

  • Research Site

    Wildomar, California

  • Research Site

    Colorado Springs, Colorado

  • Research Site

    Denver, Colorado

  • Research Site

    Denver, Colorado

  • Research Site

    New Haven, Connecticut

  • Research Site

    Clearwater, Florida

  • Research Site

    Coral Gables, Florida

  • Research Site

    Cutler Bay, Florida

  • Research Site

    Fort Lauderdale, Florida

  • Research Site

    Hialeah, Florida

  • Research Site

    Hialeah, Florida

  • Research Site

    Homestead, Florida

  • Research Site

    Homestead, Florida

  • Research Site

    Jacksonville, Florida

  • Research Site

    Kissimmee, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Ormond Beach, Florida

  • Research Site

    Pembroke Pines, Florida

  • Research Site

    Winter Park, Florida

  • Research Site

    Albany, Georgia

Showing 40 of 243 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.